Clinical Trials Logo

Clinical Trial Summary

This is an open-label, single-arm study to evaluate the safety and efficacy of bortezomib plus dexamethasone for acquired pure red cell aplasia failure or relapse after first-line treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04423367
Study type Interventional
Source Institute of Hematology & Blood Diseases Hospital, China
Contact
Status Terminated
Phase Phase 2
Start date September 13, 2020
Completion date February 6, 2024